The San Francisco-based company uses computational design to engineer RNAs that produce light when detecting desired biomolecules, enabling high-speed screening of biomanufacturing performance. Their RNA sensors allow customers to quickly screen samples using fluorescence measurements, benefiting therapeutic companies. Established in 2021, Wayfinder Biosciences aims to accelerate the production of high-value chemicals and medically relevant molecules through their innovative RNA technologies.